• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.44% Nasdaq Down 0.15%

    AbbVie Inc. (ABBV)

    -NYSE
    64.20 Down 0.31(0.48%) 10:59AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:64.51
    Open:63.91
    Bid:64.34 x 800
    Ask:64.36 x 100
    1y Target Est:76.93
    Beta:1.57619
    Earnings Date:Oct 29 - Nov 2 (Est.)
    Day's Range:63.99 - 64.78
    52wk Range:52.06 - 71.60
    Volume:1,218,509
    Avg Vol (3m):9,420,740
    Market Cap:106.27B
    P/E (ttm):49.92
    EPS (ttm):1.29
    Div & Yield:2.04 (3.18%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 0.48%106.27B
    MRKUp 0.36%155.34B
    PFEDown 1.37%202.32B

    Key Statistics

    Forward P/E (1 yr):12.80
    P/S (ttm):5.09
    Ex-Dividend Date:13-Jul-15

    Analysts

    Annual EPS Est (Dec-15) :4.26
    Quarterly EPS Est (Sep-15) :1.06
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.88

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback